Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Interim Statement of Loss and Comprehensive Loss (Unaudited)

v3.19.2
Condensed Consolidated Interim Statement of Loss and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Revenue
Expenses:        
Research and development 3,491 7,818 6,831 10,958
General and administrative 2,855 2,511 5,115 6,213
Operating Expenses 6,346 10,329 11,946 17,171
Other income (expense):        
Interest income 128 74 220 118
Foreign exchange gains (losses) (7) 2 (23)
Total other income 128 67 222 95
Net loss (6,218) (10,262) (11,724) (17,076)
Unrealized gain/(loss) on securities available-for-sale 9 (4) 18 (6)
Total comprehensive loss $ (6,209) $ (10,266) $ (11,706) $ (17,082)
Basic and diluted loss per common share (in dollars per share) $ (0.13) $ (0.30) $ (0.27) $ (0.56)
Weighted average number of common shares outstanding used in the calculation of basic and diluted loss per common share (in thousands) (in shares) 46,474 33,950 43,178 30,744